Worldwide Radiodermatitis Industry to 2027 - by Product, Distribution Channel and Region - ResearchAndMarkets.com

DUBLIN--()--The "Global Radiodermatitis Market to 2027" report has been added to ResearchAndMarkets.com's offering.

Radiodermatitis is also referred to as X-ray dermatitis, radiation dermatitis and radiation injury. It is a side effect of external beam ionizing radiation.

The rising prevalence of cancer is a key driving factor which is expected to boost the global radiodermatitis market. For Instance, in 2019, according to the American Cancer Society around 1,762,450 estimated cancer cases were diagnosed and around 606,880 cancer deaths occured in the United States. An increase in research and developments of new therapies for the treatment of radiodermatitis will have a positive impact on the market. In addition, investing in creating awareness regarding radiation skin damage is expected to fuel the market.

However, the high cost of dressings such as honey-impregnated and silicone dressings is a major restraining factor which is expected to hamper the market.

Companies Mentioned

  • Jay Pharma
  • Smith & Nephew Plc
  • Stratpharma AG
  • Kannalife Inc
  • Molnlycke Health Care
  • Intermed Pharmaceuticals
  • DermaSciences Inc
  • ConvaTec Group PLC
  • BMG Pharma S.r.l
  • Acelity Inc. (3M)

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Global Radiodermatitis Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 Global Radiodermatitis Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Global Radiodermatitis Market Share Analysis, By Product
5.3 Global Radiodermatitis Market Size and Forecast, By Product
5.3.1 Topical
5.3.1.1 Corticosteroids
5.3.1.2 Hydrophillic Creams
5.3.1.3 Antibiotics
5.3.1.4 Others
5.3.2 Oral
5.3.3 Dressings
5.3.3.1 No String barrier film
5.3.3.2 Silicone Coated dressings
5.3.3.3 Honey impregnated gauze
5.3.3.4 Others

6 Global Radiodermatitis Market, By Distribution Channel
6.1 Y-o-Y Growth Comparison, By Distribution Channel
6.2 Global Radiodermatitis Market Share Analysis, By Distribution Channel
6.3 Global Radiodermatitis Market Size and Forecast, By Distribution Channel
6.3.1 Hospital Pharmacy
6.3.2 Retail Pharmacy
6.3.3 Others

7 Global Radiodermatitis Market, By Region
7.1 Global Radiodermatitis Market Share Analysis, By Region
7.2 Global Radiodermatitis Market Share Analysis, By Region
7.3 Global Radiodermatitis Market Size and Forecast, By Region

8 North America Radiodermatitis Market Analysis and Forecast (2017 - 2027)

9 Europe Radiodermatitis Market Analysis and Forecast (2017 - 2027)

10 Asia Pacific Radiodermatitis Market Analysis and Forecast (2017 - 2027)

11 Latin America Radiodermatitis Market Analysis and Forecast (2017 - 2027)

12 Middle East Radiodermatitis Market Analysis and Forecast (2017 - 2027)

13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies

14 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/escof

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900